Spigen Korea: Low Multiples, Recovering Margins and a Share Cancellation Plan

Thesis

The data supports a picture of a profitable, nearly debt-light company priced at very low multiples. Trailing operating margin of 9.7% is above the 7.2% of 2025 and 4.7% of 2024, and free cash flow of ₩63.2B is large relative to a market value of ₩167.8B.

The data does not show revenue growth. Annual revenue was ₩463.7B in 2025, down 0.3%, and has stayed in a ₩445B to ₩465B range since 2022. Low multiples have persisted for five years, so the data does not show what would change that. Dividend yield is shown as 0.0%.

Capital return is a visible theme: filings show a treasury share sale decision in July, then a share cancellation decision in October, and news reports a ₩8.55B retirement of treasury shares. The sale and later cancellation point in different directions, and the data does not explain the reasoning.

Business overview

Spigen Korea is a KOSDAQ-listed consumer goods company, founded in 2009 and listed in November 2014, with 6,216,363 listed shares. Revenue rose from ₩385.3B in 2021 to ₩463.7B in 2025. Growth was strongest in 2022 at 15.7% and has been near flat since. Product lines, regions and customers are not in the data provided.

Financial analysis

Figures come from filed financial statements. Trailing twelve-month revenue to H1 2026 is ₩482.4B, operating income ₩46.8B and net income ₩52.2B, giving operating margin of 9.7% and net margin of 10.8%. Net income above operating income suggests non-operating gains, though the data does not give the source.

Annual operating income was ₩33.2B in 2025, ₩21.7B in 2024, ₩35.3B in 2023, ₩52.0B in 2022 and ₩44.4B in 2021. Return on equity is 9.6% trailing, versus 5.5% in 2025 and 11.9% in 2021.

The balance sheet is conservative: liabilities are 7.9% of equity, cash is ₩90.0B and borrowings are ₩9.2B. Trailing free cash flow is ₩63.2B. Enterprise value is shown as ₩7.0B, reflecting the large cash balance against the market value, though EV/EBITDA is not available.

Valuation

The stock trades at 3.2x earnings, 0.3x book value and 0.3x sales. Its own year-end history shows P/E between 4.2x and 6.2x and P/B between 0.2x and 0.7x over 2021 to 2025, so the current P/E is below each of those year-end readings while P/B is within its past range.

Among listed peers, Novatech trades at 3.5x earnings and 0.7x book, and Samick Musical Instruments at 2.3x and 0.3x. E-World is at 0.3x book, while Alux and Xplus trade at 1.9x and 2.8x book. P/E is not available for those three.

The valuation model uses a 5-year discounted cash flow at a 7.4% rate, based on trailing figures to H1 2026. It gives a base estimate of ₩100,991 per share, with a bear case of ₩68,990 and a bull case of ₩157,427. This is a model estimate based on the assumptions shown, not a target. Even the bear case is well above the ₩27,000 price, which shows how sensitive such a model is to its cash flow assumptions given flat revenue and variable margins.

Catalysts

• The shareholders' meeting called on October 20, 2026 follows the share cancellation decision and may provide detail on capital policy.
• The retirement of ₩8.55B of treasury shares reduces the share count, as reported by Money Today on October 22, 2026.
• Foreign ownership rose to 11.9% from 10.5% sixty days ago, although 20-day net foreign flow was slightly negative.
• The next financial results will show whether the trailing margin of 9.7% holds after the H1 2026 report filed on August 14.

Risks

• Revenue has been flat for several years, with 2025 down 0.3%, so earnings depend on margins rather than growth.
• Operating margin has swung between 4.7% and 11.7% since 2021, making profit hard to project.
• Net income exceeds operating income, so part of trailing profit may come from non-operating items that may not repeat.
• The shares fell 9.8% in one month and 11.6% over three months, and sit well below the 52-week high of ₩34,950.
• Dividend yield is shown as 0.0%, and low multiples have persisted for years, so returns depend on capital policy.

Closing view

The data shows a debt-light company with sizable cash, strong trailing free cash flow and valuation multiples at the low end of its own history and peers. Against that, revenue is stagnant, margins have been volatile and the market has applied low multiples for years. The model estimate is far above the current price, but it rests on assumptions that depend on margins holding. The share cancellation is a notable development, though its effect on the multiples cannot be judged from the data alone.

Model estimate of fair value

Bear

₩68,990

+148%

Base

₩100,991

+263%

Bull

₩157,427

+465%

Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.

Base case of the 5-year discounted cash flow model on the stock's Valuation tab (statements TTM to H1 2026; discount rate 7.4%). Bear and Bull move the main assumptions by fixed steps. See and change the assumptions

Filings and data used

• Share cancellation decisionOct 20, 2026
• Shareholders' meeting calledOct 20, 2026
• Notice of shareholders' meetingOct 20, 2026
• Determination of Shareholder Register Closure Period or Record DateSep 22, 2026
• Insider shareholding reportAug 21, 2026
• 5%+ holding reportAug 21, 2026
• Half-year report (Jun 2026)Aug 14, 2026
• Insider shareholding reportAug 10, 2026
• Report on Results of Disposal of Treasury SharesAug 4, 2026
• Treasury share sale decisionJul 21, 2026
• Trading Plan Report for Executives and Major Shareholders' Specific SecuritiesJun 25, 2026
• Insider shareholding reportJun 25, 2026
• Spigen Korea Retires ₩8.55B Worth of Treasury Shares; Strengthens Shareholder ReturnsOct 22, 2026
• Daily prices up to 2026-10-26
• Financial statements, trailing 12 months as of H1 2026
• Our fair value model, statements as of TTM to H1 2026

Report history

1. Oct 27, 2026InitiationStart of coverage (reader request)Spigen Korea: Low Multiples, Recovering Margins and a Share Cancellation Plan